| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
14,311 |
13,357 |
$1.79M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
3,832 |
3,435 |
$474K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
3,088 |
2,553 |
$404K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
2,653 |
1,827 |
$327K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
3,808 |
989 |
$267K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
1,788 |
1,566 |
$235K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
1,812 |
648 |
$187K |
| 70450 |
Computed tomography, head or brain; without contrast material |
661 |
509 |
$182K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
1,912 |
1,384 |
$176K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
1,628 |
551 |
$157K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
547 |
415 |
$144K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
484 |
381 |
$116K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
803 |
516 |
$115K |
| 80053 |
Comprehensive metabolic panel |
6,477 |
5,140 |
$67K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
545 |
371 |
$52K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
143 |
99 |
$49K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
1,739 |
534 |
$48K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
277 |
232 |
$43K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,191 |
938 |
$34K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
11,298 |
9,066 |
$32K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
104 |
65 |
$31K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
3,127 |
2,466 |
$27K |
| 36415 |
Collection of venous blood by venipuncture |
15,133 |
12,720 |
$27K |
| 71046 |
Radiologic examination, chest; 2 views |
833 |
698 |
$25K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
637 |
613 |
$24K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,409 |
1,180 |
$21K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
185 |
179 |
$17K |
| 73630 |
|
447 |
369 |
$17K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
46 |
41 |
$15K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
935 |
841 |
$14K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
147 |
137 |
$14K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
75 |
49 |
$13K |
| G0378 |
Hospital observation service, per hour |
446 |
80 |
$12K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
607 |
442 |
$11K |
| 80061 |
Lipid panel |
714 |
650 |
$11K |
| 73610 |
|
296 |
252 |
$8K |
| 71250 |
|
85 |
67 |
$8K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
381 |
344 |
$8K |
| 97161 |
|
200 |
146 |
$7K |
| 72100 |
|
134 |
115 |
$6K |
| 73130 |
|
171 |
140 |
$6K |
| 73030 |
|
189 |
142 |
$4K |
| 71045 |
Radiologic examination, chest; single view |
2,200 |
1,632 |
$4K |
| 73110 |
|
109 |
90 |
$4K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,797 |
2,081 |
$4K |
| 83735 |
|
1,763 |
1,190 |
$4K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
28 |
23 |
$4K |
| 94060 |
|
19 |
14 |
$4K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
16 |
16 |
$4K |
| 85610 |
|
2,493 |
1,577 |
$4K |
| 82607 |
|
171 |
158 |
$3K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
2,683 |
2,244 |
$3K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
14 |
14 |
$3K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
29 |
29 |
$3K |
| 87088 |
|
1,332 |
1,009 |
$3K |
| 84484 |
|
2,389 |
1,422 |
$3K |
| J3490 |
Unclassified drugs |
521 |
316 |
$3K |
| 71271 |
|
12 |
12 |
$2K |
| 82248 |
|
1,034 |
794 |
$2K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
17 |
15 |
$2K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
27 |
26 |
$2K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
14 |
12 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,126 |
741 |
$2K |
| 83540 |
|
129 |
117 |
$2K |
| 82570 |
|
208 |
151 |
$2K |
| 84466 |
|
95 |
88 |
$2K |
| 81001 |
|
2,965 |
2,368 |
$2K |
| 83880 |
|
864 |
607 |
$1K |
| 80076 |
|
262 |
240 |
$1K |
| 84703 |
|
956 |
754 |
$1K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
13 |
12 |
$1K |
| 90677 |
|
145 |
138 |
$1K |
| 90648 |
|
147 |
139 |
$1K |
| 86803 |
|
33 |
30 |
$1K |
| 73562 |
|
42 |
39 |
$1K |
| 82565 |
|
93 |
75 |
$1K |
| 85027 |
|
224 |
168 |
$1K |
| 83605 |
|
1,670 |
1,109 |
$1K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,766 |
1,228 |
$1K |
| 86140 |
|
89 |
61 |
$1K |
| 97162 |
|
47 |
44 |
$1K |
| 82947 |
|
923 |
262 |
$1K |
| 83655 |
|
74 |
60 |
$782.44 |
| 11721 |
|
48 |
47 |
$771.91 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
725 |
416 |
$657.15 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
90 |
86 |
$640.27 |
| 82728 |
|
27 |
24 |
$623.16 |
| 90633 |
|
64 |
60 |
$616.00 |
| 85379 |
|
755 |
589 |
$601.42 |
| 83690 |
|
1,137 |
801 |
$582.87 |
| 85730 |
|
1,384 |
1,053 |
$580.66 |
| 96376 |
|
219 |
125 |
$552.02 |
| 90723 |
|
117 |
114 |
$543.59 |
| 80069 |
|
33 |
26 |
$531.79 |
| 90680 |
|
112 |
110 |
$517.49 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
26 |
12 |
$512.35 |
| 82077 |
|
302 |
230 |
$496.20 |
| 86780 |
|
14 |
12 |
$492.93 |
| 73502 |
|
17 |
12 |
$490.08 |
| 82948 |
|
588 |
316 |
$466.79 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
858 |
723 |
$451.68 |
| 83721 |
|
16 |
16 |
$416.24 |
| 82803 |
|
842 |
477 |
$415.83 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
17 |
17 |
$415.56 |
| 82043 |
|
54 |
52 |
$411.56 |
| 81003 |
|
658 |
516 |
$405.02 |
| 87186 |
|
462 |
307 |
$382.57 |
| 84439 |
|
13 |
13 |
$368.99 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
374 |
309 |
$309.76 |
| 90661 |
|
39 |
39 |
$297.98 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
279 |
266 |
$249.73 |
| 82550 |
|
73 |
53 |
$245.43 |
| 90715 |
|
25 |
25 |
$241.50 |
| 87081 |
|
307 |
276 |
$238.36 |
| 87040 |
|
635 |
250 |
$234.26 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,201 |
751 |
$232.82 |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
14 |
14 |
$219.46 |
| 87420 |
|
197 |
165 |
$216.72 |
| 85652 |
|
45 |
26 |
$203.02 |
| 84702 |
|
14 |
13 |
$196.26 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
204 |
193 |
$192.54 |
| 90381 |
|
21 |
21 |
$177.50 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,239 |
819 |
$122.70 |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
59 |
12 |
$121.71 |
| 73080 |
|
13 |
12 |
$114.40 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
137 |
109 |
$99.16 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
27 |
25 |
$70.20 |
| 82150 |
|
56 |
44 |
$61.16 |
| 90461 |
|
211 |
203 |
$55.36 |
| 87430 |
|
95 |
95 |
$54.51 |
| 87400 |
|
166 |
162 |
$53.20 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,069 |
772 |
$46.25 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
48 |
46 |
$36.12 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
28 |
26 |
$35.86 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
89 |
70 |
$20.44 |
| 81025 |
|
78 |
73 |
$19.35 |
| 85018 |
|
52 |
48 |
$16.98 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,315 |
873 |
$11.55 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
40 |
25 |
$5.74 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
363 |
209 |
$4.56 |
| 36416 |
|
22 |
12 |
$4.26 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
126 |
101 |
$2.65 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
77 |
53 |
$1.93 |
| 87205 |
|
15 |
12 |
$1.17 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
16 |
13 |
$1.11 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
255 |
189 |
$1.09 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
38 |
27 |
$0.42 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
178 |
101 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
702 |
533 |
$0.00 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
122 |
79 |
$0.00 |
| 94760 |
|
61 |
56 |
$0.00 |
| 87280 |
|
47 |
37 |
$0.00 |
| 94761 |
|
92 |
56 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
14 |
13 |
$0.00 |
| 87147 |
|
35 |
14 |
$0.00 |
| 87077 |
|
28 |
25 |
$0.00 |
| J2060 |
Injection, lorazepam, 2 mg |
26 |
12 |
$0.00 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
30 |
14 |
$0.00 |